A 4-year-old boy presents with language delay, toe-walking, hand-flapping, and intense interest in trains. He makes poor eye contact but occasionally engages in joint attention with his mother when looking at trains. He has sensory sensitivities to loud noises. He can identify all letters and numbers but cannot have reciprocal conversations. His Childhood Autism Rating Scale (CARS) score is borderline. His parents request your opinion on diagnosis and intervention priorities given diagnostic uncertainty and limited early intervention resources in their area.
Q2
A 15-year-old girl with ADHD-predominantly inattentive type has tried methylphenidate, amphetamine salts, and atomoxetine with partial response or intolerable side effects. She has comorbid anxiety disorder and mild depression. She is motivated for treatment and has good family support. Her psychiatrist considers guanfacine as next-line therapy. Evaluate the appropriateness of this choice given her clinical profile.
Q3
A 12-year-old boy with autism spectrum disorder and intellectual disability is hospitalized for severe aggression. He is nonverbal and communicates through an augmentative device. Behavioral interventions have failed. He has been on risperidone 3 mg daily for 2 months with minimal improvement. His team considers adding a second medication. He has gained 8 kg, developed elevated prolactin (78 ng/mL), and shows early signs of gynecomastia. What is the most appropriate management strategy?
Q4
A 9-year-old boy with ADHD treated with methylphenidate develops vocal tics (throat clearing) and motor tics (eye blinking) after 8 months of treatment. His ADHD symptoms are well-controlled, but the tics are becoming socially problematic. His father had transient tics as a child. Neurological examination shows the tics but is otherwise normal. What factor most strongly suggests the tics are unmasked Tourette disorder rather than medication-induced?
Q5
A 5-year-old boy with autism spectrum disorder has severe self-injurious behavior including head-banging that has resulted in two emergency department visits. Intensive behavioral therapy has been partially effective. His parents are concerned about medication side effects but are desperate for improvement. Analysis of behavior logs shows the self-injury increases when demands are placed on him and decreases with sensory activities. What medication choice and rationale is most appropriate?
Q6
A 10-year-old girl is evaluated for academic difficulties. Her teacher reports she often daydreams, misses instructions, and makes careless errors despite adequate intelligence. She is well-behaved, quiet, and never disruptive. At home, she forgets daily tasks, frequently loses items, and has difficulty organizing schoolwork. Her mother had similar problems as a child. On examination, she is cooperative but appears distracted. What feature of her presentation would most strongly differentiate her ADHD subtype from the combined presentation?
Q7
A 6-year-old boy with autism spectrum disorder is brought for evaluation of new-onset aggression toward peers at school. He has limited verbal communication and becomes aggressive when transitions occur without warning. His special education teacher notes the aggression typically occurs during unstructured activities. Applied behavioral analysis has been partially helpful. What is the most appropriate next step in management?
Q8
An 8-year-old boy with ADHD has been taking methylphenidate for 6 months with good symptom control at school. His parents report he has lost 4 kg and his growth chart shows he has dropped from the 60th to the 25th percentile for weight. His appetite is significantly decreased, particularly at lunch. What is the most appropriate management approach?
Q9
A 4-year-old girl is evaluated for delayed speech development. She has a 10-word vocabulary and does not combine words. She avoids eye contact, engages in repetitive hand-flapping, and becomes distressed when her daily routine changes. She lines up her toys repeatedly rather than engaging in pretend play. She does not respond to her name but is not deaf. Her motor milestones were normal. What is the most likely diagnosis?
Q10
A 7-year-old boy is brought to the clinic by his mother due to poor academic performance. His teacher reports that he frequently leaves his seat, interrupts others, and fails to complete assignments. At home, he has difficulty waiting his turn during games and often loses his belongings. His mother notes these behaviors have been present since age 4 and occur both at school and home. Physical examination is unremarkable. What is the most appropriate initial pharmacological treatment?
Neurodevelopmental disorders (ADHD, autism) US Medical PG Practice Questions and MCQs
Question 1: A 4-year-old boy presents with language delay, toe-walking, hand-flapping, and intense interest in trains. He makes poor eye contact but occasionally engages in joint attention with his mother when looking at trains. He has sensory sensitivities to loud noises. He can identify all letters and numbers but cannot have reciprocal conversations. His Childhood Autism Rating Scale (CARS) score is borderline. His parents request your opinion on diagnosis and intervention priorities given diagnostic uncertainty and limited early intervention resources in their area.
A. Presume autism spectrum disorder and implement evidence-based early interventions while monitoring (Correct Answer)
B. Diagnose autism spectrum disorder and begin comprehensive ABA therapy immediately
C. Diagnose language disorder and focus resources on communication training
D. Refer to genetics for testing before committing to diagnosis or intervention
E. Delay diagnosis pending further developmental assessment and prioritize speech therapy
Explanation: ***Presume autism spectrum disorder and implement evidence-based early interventions while monitoring***
- The clinical presentation of **stereotyped behaviors** (hand-flapping, toe-walking), **restricted interests** (trains), and **social communication deficits** warrants early intervention during the critical **neuroplastic window** (ages 2-5).
- Given the diagnostic uncertainty and limited resources, a **provisional diagnosis** ensures the child receives broad-based support for functional deficits while longitudinal monitoring clarifies the diagnosis.
*Diagnose autism spectrum disorder and begin comprehensive ABA therapy immediately*
- While ASD is highly likely, a definitive diagnosis may be premature given the **borderline CARS score** and elements of **joint attention** that require further assessment.
- Immediate **comprehensive ABA therapy** might be resource-intensive and may not be the only or most appropriate option in an area with limited early intervention resources.
*Diagnose language disorder and focus resources on communication training*
- A **language disorder** diagnosis ignores the significant **repetitive behaviors**, **sensory sensitivities**, and **restricted interests** characteristic of ASD.
- Focusing solely on communication training fails to address the child's **social-emotional** and **behavioral needs**, which are central to his presentation.
*Refer to genetics for testing before committing to diagnosis or intervention*
- While **genetic testing** (e.g., chromosomal microarray) is recommended for ASD workups, it should not cause a **delay in starting intervention**.
- Genetic results rarely change the immediate **behavioral or developmental management** plan required for the child's daily functioning.
*Delay diagnosis pending further developmental assessment and prioritize speech therapy*
- Delaying diagnosis and intervention until further assessment can lead to the loss of valuable time during a peak period of **brain development**.
- Prioritizing **speech therapy** alone is insufficient because it does not address the **social reciprocity** and **sensory processing issues** evident in this patient.
Question 2: A 15-year-old girl with ADHD-predominantly inattentive type has tried methylphenidate, amphetamine salts, and atomoxetine with partial response or intolerable side effects. She has comorbid anxiety disorder and mild depression. She is motivated for treatment and has good family support. Her psychiatrist considers guanfacine as next-line therapy. Evaluate the appropriateness of this choice given her clinical profile.
A. Appropriate - guanfacine is superior to stimulants in adolescent females
B. Appropriate - alpha-2 agonist may help both ADHD and anxiety (Correct Answer)
C. Inappropriate - should try combination stimulant therapy first
D. Inappropriate - should address anxiety and depression first before ADHD
E. Inappropriate - guanfacine is only for hyperactive-impulsive ADHD symptoms
Explanation: ***Appropriate - alpha-2 agonist may help both ADHD and anxiety***
- **Guanfacine** is an **alpha-2a adrenergic agonist** that is FDA-approved for ADHD and is particularly useful when stimulants or atomoxetine have failed or caused intolerable side effects.
- For patients with **comorbid anxiety**, guanfacine is a suitable choice as it lacks the sympathomimetic effects of stimulants that can often exacerbate **anxiety symptoms**.
*Appropriate - guanfacine is superior to stimulants in adolescent females*
- There is no clinical evidence to support the claim that **alpha-2 agonists** are superior to **stimulants** based on gender or age in adolescents.
- **Stimulants** (methylphenidate and amphetamines) remain the first-line and most efficacious pharmacological treatment for ADHD across all demographics.
*Inappropriate - should try combination stimulant therapy first*
- **Combination stimulant therapy** (using two different stimulants) is not a standard evidence-based practice and increases the risk of **cardiovascular side effects** and toxicity.
- Since the patient already failed trials of both **methylphenidate** and **amphetamines**, switching to a different class like **alpha-2 agonists** is the more appropriate next step.
*Inappropriate - should address anxiety and depression first before ADHD*
- In many cases, untreated **ADHD** can contribute to secondary **anxiety** and **depressive symptoms** due to chronic academic or social struggles.
- While severe mood disorders require priority, in this stable patient, managing the **ADHD** with a non-stimulant may concurrently improve her **comorbid profile**.
*Inappropriate - guanfacine is only for hyperactive-impulsive ADHD symptoms*
- While **alpha-2 agonists** are well-known for reducing hyperactivity, they are also effective for the **inattentive subtype** by strengthening prefrontal cortex regulation.
- Clinical studies demonstrate that extended-release **guanfacine** significantly improves overall ADHD scores, including those related to **concentration and focus**.
Question 3: A 12-year-old boy with autism spectrum disorder and intellectual disability is hospitalized for severe aggression. He is nonverbal and communicates through an augmentative device. Behavioral interventions have failed. He has been on risperidone 3 mg daily for 2 months with minimal improvement. His team considers adding a second medication. He has gained 8 kg, developed elevated prolactin (78 ng/mL), and shows early signs of gynecomastia. What is the most appropriate management strategy?
A. Add metformin and continue risperidone
B. Add aripiprazole while continuing risperidone
C. Switch from risperidone to aripiprazole (Correct Answer)
D. Discontinue all antipsychotics and retry behavioral therapy
E. Increase risperidone to 4 mg daily for adequate trial
Explanation: ***Switch from risperidone to aripiprazole***
- The patient has failed an adequate trial of **risperidone** (3 mg/day for 2 months) and is experiencing significant side effects including **weight gain**, **hyperprolactinemia**, and **gynecomastia**.
- **Aripiprazole** is FDA-approved for irritability in autism and, as a **partial dopamine agonist**, it is less likely to cause prolactin elevation or metabolic side effects while offering a different mechanism for symptom control.
*Add metformin and continue risperidone*
- While **metformin** may help mitigate **antipsychotic-induced weight gain**, it does not address the lack of clinical efficacy or the symptomatic **hyperprolactinemia**.
- Continuing a medication that has failed to control **severe aggression** while adding more pharmacological complexity is not the optimal management strategy here.
*Add aripiprazole while continuing risperidone*
- Adding a second antipsychotic (**polypharmacy**) increases the risk of side effects and drug interactions without robust evidence that it improves outcomes for **irritability in autism**.
- The primary goal should be identifying an effective monotherapy specifically when the first agent has caused significant **metabolic** and **endocrine** adverse effects.
*Discontinue all antipsychotics and retry behavioral therapy*
- Complete discontinuation is risky in an inpatient setting where the patient presents with **severe aggression** and potential danger to himself or others.
- **Behavioral interventions** have already failed, and clinical guidelines recommend pharmacotherapy as an adjunct for managing severe disruptive behaviors in **autism spectrum disorder**.
*Increase risperidone to 4 mg daily for adequate trial*
- Increasing the dose is likely to worsen the **prolactin-related side effects** and **weight gain** without a guarantee of improved behavioral control.
- An 8-week trial at a therapeutic dose is considered sufficient; a lack of response at this stage suggests the patient is a **non-responder** to risperidone.
Question 4: A 9-year-old boy with ADHD treated with methylphenidate develops vocal tics (throat clearing) and motor tics (eye blinking) after 8 months of treatment. His ADHD symptoms are well-controlled, but the tics are becoming socially problematic. His father had transient tics as a child. Neurological examination shows the tics but is otherwise normal. What factor most strongly suggests the tics are unmasked Tourette disorder rather than medication-induced?
A. Social impairment from the tics
B. Eight-month delay between medication start and tic onset (Correct Answer)
C. Continued good ADHD symptom control
D. Family history of tics in the father
E. Presence of both motor and vocal tics
Explanation: ***Eight-month delay between medication start and tic onset***
- **Medication-induced tics** typically manifest within weeks of starting a stimulant; a long latency of 8 months suggest the medication is not the primary cause.
- The onset timing aligns more with the **natural progression** and emergence of a comorbid **Tourette disorder** rather than an immediate pharmacological side effect.
*Social impairment from the tics*
- **Social impairment** is a criterion for assessing the severity of the tic disorder but does not help distinguish between **idiopathic** and **drug-induced** etiologies.
- Both stimulant-induced tics and **Tourette syndrome** can cause significant distress and social functional impairment in children.
*Continued good ADHD symptom control*
- Effective management of **ADHD symptoms** with **methylphenidate** occurs independently of whether a patient develops tics as a side effect.
- The efficacy of the stimulant on the **dopaminergic system** for focus does not differentiate the underlying cause of newly appearing tics.
*Family history of tics in the father*
- While **Tourette disorder** has a strong **genetic component**, a family history only suggests susceptibility and doesn't rule out the stimulant as a trigger.
- Medication can **unmask** a genetic predisposition, but the **temporal relationship** remains the strongest evidence for differentiating the two.
*Presence of both motor and vocal tics*
- Although both **motor and vocal tics** are required for a diagnosis of **Tourette syndrome**, stimulants can theoretically exacerbate or trigger both types.
- The presence of multiple tic types confirms a complex tic disorder but does not specifically point to **Tourette's** over medication-induced onset without temporal context.
Question 5: A 5-year-old boy with autism spectrum disorder has severe self-injurious behavior including head-banging that has resulted in two emergency department visits. Intensive behavioral therapy has been partially effective. His parents are concerned about medication side effects but are desperate for improvement. Analysis of behavior logs shows the self-injury increases when demands are placed on him and decreases with sensory activities. What medication choice and rationale is most appropriate?
A. Aripiprazole - better side effect profile than risperidone
B. Fluoxetine - reduces anxiety triggering the behaviors
C. Clonidine - provides sedation to prevent injury
D. Risperidone - FDA approved for irritability in autism with self-injury (Correct Answer)
E. Methylphenidate - addresses underlying attention difficulties
Explanation: ***Risperidone - FDA approved for irritability in autism with self-injury***
- **Risperidone** is the first-line medication FDA-approved for the treatment of **irritability** associated with **Autism Spectrum Disorder (ASD)** in children ages 5-16, specifically targeting aggression, tantrum, and self-injurious behavior.
- It has the most robust evidence base for reducing **severe self-injury** when behavioral interventions, like the therapy mentioned for this patient, provide only a partial response.
*Aripiprazole - better side effect profile than risperidone*
- While **Aripiprazole** is also FDA-approved for irritability in ASD, its side effect profile is not necessarily "better"; it is associated with significant **weight gain** and **akathisia**, while risperidone is more associated with **hyperprolactinemia**.
- The choice between the two often depends on individual patient factors, but the claim that it has a strictly "better" profile is clinically inaccurate.
*Fluoxetine - reduces anxiety triggering the behaviors*
- SSRIs like **Fluoxetine** lack strong evidence for treating the core symptoms or the **irritability/aggression** aspects of ASD in pediatric populations.
- They may be used for comorbid **anxiety or OCD**, but they are not the appropriate primary choice for managing acute **self-injurious behavior (SIB)**.
*Clonidine - provides sedation to prevent injury*
- **Clonidine** is an alpha-2 agonist sometimes used for **hyperactivity** or sleep issues, but it does not address the underlying neurobiological mechanisms of **irritability** in ASD.
- Using medication purely for **sedation** to prevent injury is generally discouraged compared to using targeted stabilizers like atypical antipsychotics.
*Methylphenidate - addresses underlying attention difficulties*
- **Methylphenidate** is used to treat comorbid **ADHD symptoms** (inattention, hyperactivity), which are common in ASD but not the primary driver of this patient's **head-banging**.
- In some children with ASD, stimulants can actually **worsen irritability** or agitation, potentially exacerbating the self-injurious behavior.
Question 6: A 10-year-old girl is evaluated for academic difficulties. Her teacher reports she often daydreams, misses instructions, and makes careless errors despite adequate intelligence. She is well-behaved, quiet, and never disruptive. At home, she forgets daily tasks, frequently loses items, and has difficulty organizing schoolwork. Her mother had similar problems as a child. On examination, she is cooperative but appears distracted. What feature of her presentation would most strongly differentiate her ADHD subtype from the combined presentation?
A. Predominance of forgetfulness and disorganization
B. Normal behavior in the classroom setting
C. Absence of hyperactivity and impulsivity symptoms (Correct Answer)
D. Female gender with family history
E. Preserved intelligence with academic difficulties
Explanation: ***Absence of hyperactivity and impulsivity symptoms***
- The key clinical differentiator between **ADHD-Predominantly Inattentive Type** and **ADHD-Combined Type** is the lack of symptoms such as restlessness, interrupting others, or being "on the go."
- This patient demonstrates significant **inattentive symptoms** (careless errors, daydreaming) while remaining **quiet and well-behaved**, which excludes the combined presentation.
*Predominance of forgetfulness and disorganization*
- While these are hallmarks of inattention, they occur in **both** the predominantly inattentive and the combined subtypes of ADHD.
- These features describe the **severity of inattention** but do not help in ruling out the presence of concurrent hyperactivity.
*Normal behavior in the classroom setting*
- While the patient is not disruptive, her behavior is not "normal" as she **misses instructions** and performs poorly due to inattention.
- Even in combined type, behavior can vary by setting, so **compliance** alone is not a diagnostic differentiator for the subtype.
*Female gender with family history*
- Although **ADHD-Inattentive type** is more frequently diagnosed in females and ADHD has a strong **genetic component**, these are demographic and risk factors rather than diagnostic criteria.
- Gender and family history cannot be used to clinically distinguish between specific **behavioral subtypes** during a presentation.
*Preserved intelligence with academic difficulties*
- A mismatch between **intelligence and academic performance** is a common reason for ADHD referral but is seen in all subtypes and **Learning Disorders**.
- This feature identifies the **functional impairment** caused by the disorder rather than defining the specific symptomatic profile of the subtype.
Question 7: A 6-year-old boy with autism spectrum disorder is brought for evaluation of new-onset aggression toward peers at school. He has limited verbal communication and becomes aggressive when transitions occur without warning. His special education teacher notes the aggression typically occurs during unstructured activities. Applied behavioral analysis has been partially helpful. What is the most appropriate next step in management?
A. Start an SSRI for associated anxiety
B. Increase structure with visual schedules and transition warnings (Correct Answer)
C. Start risperidone for aggression
D. Functional behavioral assessment to identify triggers
E. Change to a more restrictive educational setting
Explanation: ***Increase structure with visual schedules and transition warnings***
- Behavioral interventions are the first-line treatment for aggression in **Autism Spectrum Disorder (ASD)** when specific environmental triggers like **unstructured activities** or **transitions** are identified.
- Providing **visual schedules** and clear warnings helps mitigate the anxiety of unpredictability, addressing the root cause of the disruptive behavior without medication.
*Start an SSRI for associated anxiety*
- **SSRIs** are not indicated for the primary management of aggression in children with ASD and are generally reserved for comorbid **anxiety** or **obsessive-compulsive** symptoms.
- They may actually cause **behavioral activation** or increased agitation in some pediatric patients, potentially worsening the aggression.
*Start risperidone for aggression*
- While **risperidone** and **aripiprazole** are FDA-approved for irritability and aggression in ASD, they should only be used if **behavioral interventions** fail.
- These medications carry significant risks of side effects, including **weight gain**, **metabolic syndrome**, and **extrapyramidal symptoms**.
*Functional behavioral assessment to identify triggers*
- A **Functional Behavioral Assessment (FBA)** is used to identify the purpose behind a behavior; however, in this vignette, the triggers (unstructured time and transitions) have **already been identified**.
- The immediate next step is to implement the **targeted intervention** based on the factors that are already known to provoke the aggression.
*Change to a more restrictive educational setting*
- Managing school-based aggression should focus on the **Least Restrictive Environment (LRE)** by modifying the current setting before moving to a more segregated placement.
- Transitioning to a more restrictive setting is considered **premature** before optimizing behavioral supports and classroom structure in the current environment.
Question 8: An 8-year-old boy with ADHD has been taking methylphenidate for 6 months with good symptom control at school. His parents report he has lost 4 kg and his growth chart shows he has dropped from the 60th to the 25th percentile for weight. His appetite is significantly decreased, particularly at lunch. What is the most appropriate management approach?
A. Increase methylphenidate dose to improve focus on eating
B. Provide nutritional supplementation and drug holidays on weekends (Correct Answer)
C. Switch to atomoxetine
D. Add a second stimulant medication
E. Discontinue methylphenidate immediately
Explanation: ***Provide nutritional supplementation and drug holidays on weekends***
- **Appetite suppression** and **weight loss** are common side effects of **stimulants**; management involves calorie-dense meals and "drug holidays" to allow for **catch-up growth**.
- Since the medication is providing **good symptom control**, these behavioral and dietary adjustments take priority over discontinuing an effective treatment.
*Increase methylphenidate dose to improve focus on eating*
- Increasing the dose of **methylphenidate** would exacerbate **appetite suppression** and lead to further **weight loss**.
- Stimulants act on the **hypothalamus** to reduce hunger signals, and this effect is generally **dose-dependent**.
*Switch to atomoxetine*
- While **atomoxetine** (a non-stimulant) may have less impact on weight, it generally has **lower efficacy** than stimulants for ADHD.
- Switching is unnecessary when side effects can be managed with **nutritional support** and the current drug is working well.
*Add a second stimulant medication*
- Adding a second stimulant would likely worsen **anorexia** and **growth retardation** without clinical benefit.
- **Polypharmacy** with multiple stimulants is not standard practice and increases the risk of **cardiovascular** and **psychiatric** adverse effects.
*Discontinue methylphenidate immediately*
- Immediate discontinuation is not warranted as the patient has **good symptom control** and the weight loss is not life-threatening.
- Stopping the medication would lead to a return of **ADHD symptoms**, which could negatively impact the child's **academic performance** and social functioning.
Question 9: A 4-year-old girl is evaluated for delayed speech development. She has a 10-word vocabulary and does not combine words. She avoids eye contact, engages in repetitive hand-flapping, and becomes distressed when her daily routine changes. She lines up her toys repeatedly rather than engaging in pretend play. She does not respond to her name but is not deaf. Her motor milestones were normal. What is the most likely diagnosis?
A. Social communication disorder
B. Selective mutism
C. Autism spectrum disorder (Correct Answer)
D. Rett syndrome
E. Childhood-onset fluency disorder
Explanation: ***Autism spectrum disorder***
- Characterized by persistent deficits in **social communication** and **social interaction**, such as avoiding eye contact, lack of response to name, and delayed speech.
- Requires the presence of **restricted, repetitive patterns** of behavior or interests, exemplified here by hand-flapping, lining up toys, and distress with routine changes.
*Social communication disorder*
- Involves primary difficulties with the **social use of verbal and nonverbal communication** without the presence of restricted or repetitive behaviors.
- This diagnosis is excluded because the patient demonstrates **repetitive hand-flapping** and fixed adherence to routines.
*Selective mutism*
- Characterized by a consistent **failure to speak in specific social situations** (e.g., school) despite speaking in other situations like at home.
- Unlike this patient, children with selective mutism typically have **normal social communication skills** in familiar environments and lack repetitive motor behaviors.
*Rett syndrome*
- Typically involves a period of normal development followed by a **regression** in motor, language, and social skills, primarily in females around 6-18 months of age.
- Features characteristic **deceleration of head growth** and lose of purposeful hand skills, often replaced by midline hand-wringing rather than simple flapping.
*Childhood-onset fluency disorder*
- Also known as **stuttering**, this disorder is characterized by disturbances in the normal fluency and time patterning of speech.
- It does not involve deficits in **social reciprocity**, lack of eye contact, or the repetitive behaviors seen in this clinical case.
Question 10: A 7-year-old boy is brought to the clinic by his mother due to poor academic performance. His teacher reports that he frequently leaves his seat, interrupts others, and fails to complete assignments. At home, he has difficulty waiting his turn during games and often loses his belongings. His mother notes these behaviors have been present since age 4 and occur both at school and home. Physical examination is unremarkable. What is the most appropriate initial pharmacological treatment?
A. Risperidone
B. Atomoxetine
C. Clonidine
D. Methylphenidate (Correct Answer)
E. Fluoxetine
Explanation: ***Methylphenidate***
- **Methylphenidate** and other **stimulants** are considered the first-line pharmacological treatment for **ADHD** due to their high efficacy and superior response rates in children aged 6 years and older.
- It works by increasing the levels of **synaptic dopamine** and **norepinephrine** in the prefrontal cortex, helping to regulate attention and behavior.
*Risperidone*
- This is an **atypical antipsychotic** primarily used for the management of **irritable behavior** in autism or **conduct disorder**, rather than core ADHD symptoms.
- High side-effect profile, including **weight gain** and **metabolic changes**, makes it inappropriate as an initial treatment for uncomplicated ADHD.
*Atomoxetine*
- While it is a **non-stimulant** medication approved for ADHD, it is generally considered a second-line option when **stimulants** are ineffective or contraindicated.
- It has a **slower onset of action** (weeks) compared to the rapid effect of methylphenidate.
*Clonidine*
- This is an **alpha-2 adrenergic agonist** typically used as an adjunct or second-line treatment, especially for patients with comorbid **tics** or significant **sleep disturbances**.
- It is less effective for **inattentive symptoms** compared to stimulants and can cause significant **sedation** and hypotension.
*Fluoxetine*
- This is a **Selective Serotonin Reuptake Inhibitor (SSRI)** indicated for **Major Depressive Disorder** or **Anxiety**, which are not the primary issues described here.
- It has no proven efficacy in treating the core symptoms of **hyperactivity**, **impulsivity**, or **inattention** seen in ADHD.
